Hilde Bakke|Bjørn Haneberg - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 7, 2006

[The development of mucosal vaccines]Hilde Bakke, Bjørn Haneberg

Infection and Immunity|September 14, 2002

Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccinesLibuse Janakova, Hilde Bakke, Inger Lise Haugen, et al.

Vaccine|May 20, 2004

Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memoryHilde Bakke, Torhild N Setek, Phuong N Huynh, et al.

Expert Review of Vaccines|August 7, 2003

Can nonliving nasal vaccines be made to work?Bjørn Haneberg, Johan Holst

Vaccine|November 8, 2003

Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccinesAnita Haugan, Phuong Xuan Thi Dao, Nina Glende, et al.

Open Forum Infectious Diseases|March 24, 2016

A Missed Summer Wave of the 1918-1919 Influenza Pandemic: Evidence From Household Surveys in the United States and NorwaySvenn-Erik Mamelund, Bjørn Haneberg, Siri Mjaaland

Human Vaccines|October 14, 2006

A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvantsHelvi Holm Samdal, Hilde Bakke, Fredrik Oftung, et al.

Journal of Virological Methods|July 16, 2014

Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicityJennifer L Dembinski, Olav Hungnes, Anna Germundsson Hauge, et al.

Clinical and Vaccine Immunology : CVI|June 17, 2011

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activityAudun Aase, Tove Karin Herstad, Samuel Merino, et al.

Vaccine|May 6, 2008

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in NorwayDidrik F Vestrheim, Oistein Løvoll, Ingeborg S Aaberge, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 7, 2006

[The development of mucosal vaccines]Hilde Bakke, Bjørn Haneberg

Infection and Immunity|September 14, 2002

Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccinesLibuse Janakova, Hilde Bakke, Inger Lise Haugen, et al.

Vaccine|May 20, 2004

Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memoryHilde Bakke, Torhild N Setek, Phuong N Huynh, et al.

Expert Review of Vaccines|August 7, 2003

Can nonliving nasal vaccines be made to work?Bjørn Haneberg, Johan Holst

Vaccine|November 8, 2003

Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccinesAnita Haugan, Phuong Xuan Thi Dao, Nina Glende, et al.

Open Forum Infectious Diseases|March 24, 2016

A Missed Summer Wave of the 1918-1919 Influenza Pandemic: Evidence From Household Surveys in the United States and NorwaySvenn-Erik Mamelund, Bjørn Haneberg, Siri Mjaaland

Human Vaccines|October 14, 2006

A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvantsHelvi Holm Samdal, Hilde Bakke, Fredrik Oftung, et al.

Journal of Virological Methods|July 16, 2014

Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicityJennifer L Dembinski, Olav Hungnes, Anna Germundsson Hauge, et al.

Clinical and Vaccine Immunology : CVI|June 17, 2011

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activityAudun Aase, Tove Karin Herstad, Samuel Merino, et al.

Vaccine|May 6, 2008

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in NorwayDidrik F Vestrheim, Oistein Løvoll, Ingeborg S Aaberge, et al.

Pageof 2